AN2 Therapeutics Inc.
ANTX | NASDAQ
$4.53
-$0.16 (-3.41%)
At close: Oct 30, 2026, 4:00 PM ET
$4.53
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 5:27 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -8.19M | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.55M | -6.94M | -5.01M | -2.05M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 414K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 972K | 1.46M | 1.4M | 801K | 2M | 2.05M | 1.78M | 1.9M | 2.27M | 2.39M | 2.23M | 2.17M | 1.94M | 2.07M | 1.47M | 1.23M | 1.24M | 449K | 433K | 354K | 179K | 8K |
Other Working Capital | 902K | -3.02M | 1.4M | 2.28M | -1.88M | -1.34M | -570K | -257K | -782K | -2.03M | 1.01M | 1.73M | 1.89M | 652K | 2.41M | 1.02M | -1.1M | -1.1M | -958K | 1.17M | -713K | 118K |
Other Non-Cash Items | 311K | -81K | -117K | -211K | -299K | -443K | -567K | -731K | -890K | -1.09M | -1.72M | -640K | -440K | -416K | -355K | -225K | -54K | 19K | 23K | 19K | 11K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -96K | -3.42M | 2.19M | 2.39M | -2.84M | -1.58M | 1.04M | -431K | -1.33M | -2.27M | -1.1M | 3.38M | 1.48M | 2.08M | 3.09M | 849K | -663K | 445K | -1.9M | 1.88M | -440K | 497K |
Operating Cash Flow | -7M | -12.07M | -5.24M | -6.38M | -7.6M | -10.62M | -5.27M | -12.01M | -14.38M | -17.59M | -17.07M | -11.8M | -12.82M | -11.6M | -7.64M | -9.49M | -9.6M | -6.74M | -8.99M | -4.69M | -5.26M | -1.54M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -13.66M | -2.7M | -8.33M | -3.89M | -11.67M | -22.31M | -24.38M | -9.78M | -12.59M | n/a | -19.83M | -85.21M | -13.12M | -14.01M | -17.45M | -22.41M | -52.99M | -998K | -16M | -11.99M | -49.28M | n/a |
Sales Maturities Of Investments | 10M | 10.99M | 15.5M | 10M | 17.5M | 31.5M | 17.5M | 28.5M | 29.05M | 26.29M | 20.25M | 22.75M | 21M | 24.9M | 23.5M | 20.09M | 13.5M | 14.98M | 22.25M | 5M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -3.66M | 8.29M | 7.17M | 6.11M | 5.83M | 9.19M | -6.88M | 18.72M | 16.46M | 26.29M | 420K | -62.46M | 7.88M | 10.89M | 6.06M | -2.32M | -39.49M | 13.98M | 6.25M | -6.99M | -49.28M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -272K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 266K | n/a | 199K | n/a | n/a | n/a | -11K | -969K | -240K | n/a | 10K |
Financial Cash Flow | 1.49M | 37.33M | n/a | 48K | n/a | 65K | n/a | 23K | n/a | 349K | -321K | 66.07M | 19.05M | 199K | n/a | -10K | 7.18M | 63.19M | -969K | -240K | n/a | 79.74M |
Net Cash Flow | -9.17M | 33.55M | 1.94M | -217K | -1.77M | -1.37M | -12.15M | 6.74M | 2.08M | 9.05M | -16.97M | -8.2M | 14.1M | -510K | -1.58M | -11.81M | -41.9M | 70.42M | -3.72M | -11.92M | -54.54M | 78.2M |
Free Cash Flow | -7M | -12.07M | -5.24M | -6.38M | -7.6M | -10.62M | -5.27M | -12.01M | -14.38M | -17.59M | -17.07M | -11.8M | -12.82M | -11.6M | -7.64M | -9.49M | -9.6M | -6.74M | -8.99M | -4.69M | -5.26M | -1.54M |
Adj. Free Cash Flow | -7.97M | -13.53M | -6.64M | -7.18M | -9.6M | -12.67M | -7.05M | -13.91M | -16.66M | -19.98M | -19.3M | -13.97M | -14.77M | -13.66M | -9.11M | -10.72M | -10.84M | -7.19M | -9.43M | -5.05M | -5.44M | -1.55M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -7M | -12.07M | -5.24M | -6.38M | -7.6M | -10.62M | -5.27M | -12.01M | -14.38M | -17.59M | -17.07M | -11.8M | -12.82M | -11.6M | -7.64M | -9.49M | -9.6M | -6.74M | -8.99M | -4.69M | -5.26M | -1.54M |
Add to Watchlist
Select watchlists to add or remove ANTX